|
Name |
(3E)-3-ethylidene-3a-methyl-2,4,5,6,7,7a-hexahydro-1H-indene
|
Molecular Formula | C12H20 | |
IUPAC Name* |
(3E)-3-ethylidene-3a-methyl-2,4,5,6,7,7a-hexahydro-1H-indene
|
|
SMILES |
C/C=C/1\CCC2C1(CCCC2)C
|
|
InChI |
InChI=1S/C12H20/c1-3-10-7-8-11-6-4-5-9-12(10,11)2/h3,11H,4-9H2,1-2H3/b10-3+
|
|
InChIKey |
PLNRDADPGQMIIQ-XCVCLJGOSA-N
|
|
Synonyms |
(3E)-3-ethylidene-3a-methyl-2,4,5,6,7,7a-hexahydro-1H-indene; (1E)-1-Ethylidene-7a-methyloctahydro-1H-indene #; (3e)-3-ethylidene-3a-methyl-2,4,5,6,7,7a-hexahy-dro-1h-indene; 1H-Indene, 1-ethylideneoctahydro-7a-methyl-, (1E,3a.alpha.,7a.beta.)-
|
|
CAS | NA | |
PubChem CID | 5373026 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 164.29 | ALogp: | 4.3 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 12 | QED Weighted: | 0.46 |
Caco-2 Permeability: | -4.469 | MDCK Permeability: | 0.00001470 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.172 |
30% Bioavailability (F30%): | 0.91 |
Blood-Brain-Barrier Penetration (BBB): | 0.412 | Plasma Protein Binding (PPB): | 94.16% |
Volume Distribution (VD): | 2.709 | Fu: | 2.77% |
CYP1A2-inhibitor: | 0.739 | CYP1A2-substrate: | 0.846 |
CYP2C19-inhibitor: | 0.465 | CYP2C19-substrate: | 0.916 |
CYP2C9-inhibitor: | 0.245 | CYP2C9-substrate: | 0.759 |
CYP2D6-inhibitor: | 0.191 | CYP2D6-substrate: | 0.835 |
CYP3A4-inhibitor: | 0.167 | CYP3A4-substrate: | 0.255 |
Clearance (CL): | 10.022 | Half-life (T1/2): | 0.158 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.238 |
Drug-inuced Liver Injury (DILI): | 0.075 | AMES Toxicity: | 0.022 |
Rat Oral Acute Toxicity: | 0.033 | Maximum Recommended Daily Dose: | 0.409 |
Skin Sensitization: | 0.518 | Carcinogencity: | 0.167 |
Eye Corrosion: | 0.546 | Eye Irritation: | 0.978 |
Respiratory Toxicity: | 0.814 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005521 | 0.313 | D0P6VV | 0.288 | ||||
ENC001339 | 0.304 | D0G8BV | 0.256 | ||||
ENC000592 | 0.296 | D03DVJ | 0.250 | ||||
ENC003255 | 0.293 | D07XJM | 0.244 | ||||
ENC001341 | 0.286 | D0H1QY | 0.235 | ||||
ENC002337 | 0.279 | D09OBB | 0.227 | ||||
ENC000926 | 0.274 | D0K0EK | 0.224 | ||||
ENC001079 | 0.271 | D04DJN | 0.224 | ||||
ENC000613 | 0.271 | D06XMU | 0.224 | ||||
ENC000482 | 0.271 | D07QKN | 0.222 |